Award
NIH Reporter #5R43AI195168-02
A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines
Recipient
IMMPORT THERAPEUTICS, INC.
Award Amount
$292,254.00
Ceiling
$292,254.00
Awarded
August 06, 2026
Identifier
5R43AI195168-02
Award for developing a serology test to evaluate potency of whole cell Pertussis vaccines, funded by NIH, aiming to replace outdated methods with reliable serology-based testing.
Description
The project involves developing a serological potency test for whole cell Pertussis vaccines. The project is funded by the NIH and involves collaboration with the Wadsworth Center, NYS Department of Health. It aims to replace the outdated Kendrick assay with a more reliable serology-based test, including microarray development, mouse model testing, and assay qualification. This is part of a broader effort to improve vaccine evaluation and manufacturing.